Test Usage. The Cobas HPV is a qualitative in vitro test for the detection of Human Papillomavirus in clinician-collected cervical specimens using an endocervical brush/spatula or broom and placed in the ThinPrep® Pap Test™ PreservCyt® Solution. This test detects the high-risk HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 However, HPV DNA testing can lead to a missed diagnosis rate for cervical cancer of approximately 19%; even after patients are infected with HPV, their HPV testing results may not be positive, as the positivity of HPV testing can be affected by multiple factors, such as the presence of cancer . The HPV DNA test may be done during a Pap test. If they are done together, it is called "co-testing." You lie on a table and place your feet in footrests. Your health care provider inserts an instrument (called a speculum) into the vagina to open it slightly. This allows the provider to see the cervix. Cells are gently collected from the cervix The bottom line is that most who have genital HPV DNA detected in research studies eventually test negative, often within a year or two.Many researchers and clinicians do believe “subclinical” HPV (virus may be in skin cells but no lesions are present) is less likely to be transmitted than when warts or cell changes are detected, probably This test utilizes transcription-mediated amplification (TMA) technology and detects mRNA from 14 high-risk HPV types associated with cervical cancer.4 Aptima detects HPV type 16 and HPV types 18/45 (18 is not differentiated from type 45).4 The cobas® HPV DNA Test This test utilizes an amplified molecular technology known as “polymerase *Co-Testing: Cervical cytology plus the HPV co-test is performed on the same date of service. The result of the HPV test is reported regardless if the Pap has a positive or negative result. ** Reflex: Cervical cytology with reflex HPV testing means if the result of the Pap is ASC-US, then the HPV sample is ran by the laboratory. The new test, designated careHPV, is a signal-amplification assay that detects target HPV-DNA from 14 different carcinogenic HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68). The assay needs only a small footprint of bench-top work space (about 25×50 cm), no mains electricity or running water, and can be done by technical HR-HPV testing is therefore essential in cervical cancer screening. Although various HPV-DNA detection tests exist, the five US Food and Drug Administration (US FDA)-approved assays detect only the HR-HPV types [18,19]. It has been reported that HR-HPVs testing showed a significant sensitivity for detecting CIN2+ lesions [20,21,22]. Vay Tiền Nhanh Chỉ Cần Cmnd Asideway.

hpv dna test negative means